1. Home
  2. EU vs SOPH Comparison

EU vs SOPH Comparison

Compare EU & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enCore Energy Corp.

EU

enCore Energy Corp.

HOLD

Current Price

$1.61

Market Cap

361.2M

ML Signal

HOLD

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$5.04

Market Cap

374.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EU
SOPH
Founded
2009
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.2M
374.1M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
EU
SOPH
Price
$1.61
$5.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$4.00
$7.50
AVG Volume (30 Days)
2.8M
89.3K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
11.76
N/A
EPS
0.03
N/A
Revenue
$43,155,000.00
N/A
Revenue This Year
$212.11
$23.09
Revenue Next Year
$29.88
$19.57
P/E Ratio
$52.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.34
$2.59
52 Week High
$4.19
$5.70

Technical Indicators

Market Signals
Indicator
EU
SOPH
Relative Strength Index (RSI) 44.87 54.80
Support Level $1.34 $4.54
Resistance Level $2.17 $5.46
Average True Range (ATR) 0.10 0.34
MACD 0.01 0.03
Stochastic Oscillator 65.00 61.25

Price Performance

Historical Comparison
EU
SOPH

About EU enCore Energy Corp.

enCore Energy Corp together with its subsidiary, is principally engaged in the acquisition, exploration, development and extraction of uranium resource properties in the United States. The Company is focused on the extraction of domestic uranium in the United States. The Company utilizes the In-Situ Recovery technology (ISR) to provide necessary fuel for the generation of clean, reliable, and carbon-free nuclear energy.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: